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Abstract. The properties as biointerfaces of electroactive conducting polymer-peptide 
biocomposites formed by poly(3,4-ethylenedioxythiophene) (PEDOT) and CREKA or 
CR(NMe)EKA peptide sequences (where Glu has been replaced by N-methyl-Glu in the 
latter) have been compared. CREKA is linear pentapeptide that recognizes clotted 
plasma proteins and selectively homes to tumors, while CR(NMe)EKA was engineer to 
improve such properties by altering peptide···fibrin interactions. Differences between 
PEDOT-CREKA and PEDOT-CR(NMe)EKA reflect dissemblance in the organization 
of the peptides into the polymeric matrix. Both peptides affect fibrinogen thrombin–
catalyzed polymerization causing the immediate formation of fibrin, whereas in absence 
of thrombin this phenomenon is only observed for CR(NMe)EKA. Consistently, the 
fibrin-adsorption capacity is higher for PEDOT-CR(NMe)EKA than for PEDOT-
CREKA, even though in both cases adsorbed fibrin exhibits round-like morphologies 
rather than the characteristic fibrous structure. PEDOT-peptide films coated with fibrin 
are selective in terms of cell adhesion, promoting the attachment of metastatic cells with 
respect to normal cells.  
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1. Introduction 
Biocomposites derived from the conjugation of synthetic polymers with 
biomolecules (e.g. proteins and peptides) are frequently used in biomedicine because of 
the synergistic effects associated to combination of their individual properties.
[1,2]
 In the 
last few years, particular attention has been paid to biocomposites involving 
electroactive conducting polymers (ECPs), which due to their excellent properties
[3]
 are 
used to fabricate electrochemically active biointerfaces. Thus, devices based on the 
combination of ECPs and biomolecules have been successfully used applications, as for 
example bioinspired channels for ion-exchange
[4]
 electromechanical actuators,
[5]
 
components of bioelectronics devices,
[6]
 aerogels for nerve regeneration,
[7]
 and bioactive 
platforms for tissue regeneration that mimic the growth of biological tissues.
[8]
 
CREKA (Cys-Arg-Glu-Lys-Ala) is a linear pentapeptide that recognizes clotted 
plasma proteins and selectively homes to tumors.
[9]
 Thus, this peptide, which was 
identified using in vivo screening of phage-display peptide libraries,
[10]
 recognizes the 
interaction of fibrin-fibronectin accumulated in walls of tumor vessels and in the 
interstitial spaces within tumors.
[9] 
Tumor vessels are less robust and stable than normal 
vasculature, favoring the release of some molecules such as fibrinogen (Fg), which is 
the fibrin precursor.
[11]
 Leaked Fg is converted into a fibrin meshwork by the action of 
thrombin (THR), which cleavages and removes fibrinopeptides allowing the self-
assembly of fibrin monomers into elongated fibers.
[12]
 CREKA linked to amino-dextran 
coated superparamagnetic iron oxide (SPIO) nanoparticles not only binds to clotted 
plasma proteins blood and plasma but also induces further localized tumor clotting.
[9]
 
This amplified system enhanced the homing of the nanoparticles in a mouse tumor 
model and the tumor imaging, without causing clotting or other obvious side effects 
elsewhere in the body. CREKA also homes to the surface of atherosclerotic plaques, 
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including bivalirudin (i.e. a THR inhibitor that selectively and reversibly binds the 
active site of free and fibrin bound THR) containing micelles, and has been used to 
deliver and concentrate payloads onto atherosclerotic plaques in the ApoE-null mouse 
model.
[13]
 
The energy landscape and bioactive conformation of CREKA, which consists in a 
pocket-like shape with the charged groups of Arg, Glu and Lys pointing outwards to 
facilitate the formation of intermolecular interactions, were determined using computer 
assisted modelling tools.
[14]
 This information was used to engineer variants of CREKA 
peptide to resists proteolysis by targeted replacements.
[15]
 More specifically, peptide 
analogues that incorporate the synthetic -methyl and N-methyl derivatives of Arg, Glu 
and Lys were studied. Interestingly, CREKA analogues were more effective in tumor 
homing than the original peptide, results being particularly good for the CREKA 
analogue in which the Glu was replaced by N-methyl-Glu, CR(NMe)EKA.
[16]
 
Additionally, in a very recent study She et al.
[17]
 reported that CR(NMe)EKA retains 
almost completely the anticoagulant activity of the THR inhibitor bivalirudin.  In a very 
recent work we reported the conditions required for the preparation of bioactive 
platforms based on the modification of an effective ECP with CREKA.
[2]
 The polymer 
selected for such purpose was poly(3,4-ethylenedioxythiophene) (PEDOT), which is 
among the most successful ECPs due to its excellent electrochemical and thermal 
properties, high conductivity, good environmental stability in its doped state, 
mechanical flexibility, relative ease of preparation, biocompatibility, and fast doping-
undoping process.
[18]
 PEDOT-CREKA biocomposites prepared by chronoamperometry 
in basic aqueous solution (pH= 10.3) and deposited onto a PEDOT internal layer (i.e. 
forming a bilayered system) were found to entrap one peptide molecule every six 
polymer repeat units. Although the morphology and topography of PEDOT-CREKA 
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were completely different to those of the individual ECP, the impact of the entrapped 
peptide molecules in the excellent electrochemical properties of PEDOT was found to 
be practically negligible.  Herein, we prepare and characterize a biocomposite based on 
the combination of PEDOT and CR(NMe)EKA, PEDOT-CR(NMe)EKA. This new 
material has been obtained by adapting the strategy previously used for PEDOT-
CREKA
[2]
 to achieve both (i) a reduction of an order of magnitude in the thickness of 
the films, and (ii) an improvement of the electrochemical behavior with respect to pure 
PEDOT. Results indicate that the replacement of Glu by N-methyl-Glu affects 
considerably the biocomposite···fibrin interactions, greatly influencing the properties 
and response of fibrin-coated biocomposites. Moreover, fibrin-coated PEDOT-
CR(NMe)EKA exhibits a remarkable capacity to differentiate between normal and 
tumor cells. Thus, such ECP-peptide-protein biocomposite is a very promising material 
for biomedical applications.  
 
2. Experimental Section 
Materials as well as extended version of the synthetic and characterization protocols 
are provided in the Supporting Information (S.I.). 
 
2.1. Synthesis 
Anodic polymerization and electrochemical assays were performed with an Autolab 
PGSTAT302N equipped with the ECD module (Ecochimie, the Netherlands) using a 
three-electrode compartment cell under nitrogen atmosphere (99.995% pure) at room 
temperature. Steel AISI 316 sheets of 0.5 and 1 cm
2
 in area were used as working and 
counter electrode, respectively. The reference electrode was an Ag׀AgCl electrode 
containing a KCl saturated aqueous solution.  
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PEDOT-CR(NMe)EKA and PEDOT-CREKA films were prepared by 
chronoamperometry using an aqueous medium pH = 10.3 (adjusted with 1 M NaOH) 
and a constant potential of 1.10 V using dodecylbenzene sulfonate (SDBS) as 
supporting electrolyte. Initially, a coating layer of PEDOT was deposited onto the steel 
electrode using a monomer solution and a polymerization time of = 10 s. After this, a 
second layer of PEDOT-CR(NMe)EKA or PEDOT-CREKA was electrodeposited onto 
the surface of the PEDOT coating layer. This was achieved by including in the anodic 
compartment a mixture of monomer and CR(NMe)EKA or CREKA peptide and using a 
polymerization time of = 20 s. It should be remarked that the biocomposite layer was 
deposited onto the internal PEDOT layer immediately after the generation of the latter, 
which represents an important difference with respect to previous work.
[2]
 PEDOT films 
used as control were prepared employing the same experimental conditions that for 
PEDOT-peptide biocomposites but without the peptide addition in the second layer.  
 
2.2. Characterization 
Film thickness measurements were carried out using a Dektak 150 stylus 
profilometer (Veeco, Plainview, NY). AFM was conducted to obtain topographic 
images of the films surface using silicon TAP 150-G probe (Budget Sensors, Bulgaria) 
with a frequency of 150 kHz and a force constant of 5 N/m. Images were obtained with 
an AFM Dimension microscope using a NanoScope IV controller under ambient 
conditions in tapping mode. The scan window size was 1010 m2. 
X-ray photoelectron spectroscopy (XPS) analyses were performed in a SPECS 
system equipped with a high-intensity twin-anode X-ray source XR50 of Mg/Al (1253 
eV/1487 eV) operating at 150 W, placed perpendicular to the analyzer axis, and using a 
Phoibos 150 MCD-9 XP detector. The X-ray spot size was 650 mm. The pass energy 
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was set to 25 and 0.1 eV for the survey and the narrow scans, respectively. The C 1s 
peak was used as an internal reference with a binding energy of 284.8 eV.  
Cyclic voltammetry (CV) studies were run to assess the electrochemical behavior of 
the biocomposites. Hence, the ability to exchange charge reversibly (i.e. electroactivity) 
and the electrochemical stability (i.e. electrostability) were determined using a 0.1 M 
phosphate buffer saline solution (PBS; pH= 7.4 adjusted with NaOH). The initial and 
final potentials were -0.40 V, whereas a reversal potential of 0.80 V was considered. 
The scan rate was 50 mV/s in all cases. The electrochemical stability (i.e. loss of 
electroactivity, LEA) was determined using the following expression: 
 100
iQ
Q
LEA

  (1) 
where ΔQ is the difference of voltammetric charge between the first cycle and the last 
cycle and Qi is the voltammetric charge corresponding to the second cycle.  
Real-time monitoring of fibrin polymerization in presence and absence of peptide at 
37 ºC was conducted by Dynamic light scattering (DLS) following the increment of the 
particle effective diameter. Final concentrations of Fg and thrombin (THR) were 0.4 
mg/mL and 0.01 U/mL, respectively, in aqueous solution containing 5 mM CaCl2 and 
76 mM NaCl. Data were collected every minute. Measurements were performed using a 
NanoBrook Omni Zeta Potential Analyzer from Brookheaven Instruments Corporation. 
Electrochemical impedance spectroscopy (EIS) was performed using a conventional 
three-electrode cell and AUTOLAB-302N potentiostat/galvanostat operating between 
the frequency range of 100kHz-10 mHz and 10 mV of amplitude for the sinusoidal 
voltage. All experiments were performed with films electrochemically deposited on 
stainless steel substrates (AISI 316L with 1cm
2
 of area) and immersed in phosphate 
buffer saline (PBS, pH 7.4), at room temperature.  
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Scanning electron microscopy (SEM) micrographs were obtained using a Focussed 
Ion Beam Zeiss Neon 40 scanning electron microscope operating at 10 kV. 
Furthermore, THR-catalyzed fibrin particles were also observed by optical microscopy. 
Contact angle (CA) measurements were conducted using the water drop method. 0.5 
µL of milliQ water drops were deposited onto the surface of the films and recorded after 
stabilization with the equipment OCA 15EC (DataPhysics Instruments GmbH, 
Filderstadt).  
 
2.3. Protein Adsorption  
Analyses to examine the adsorption of proteins onto the surface of PEDOT, PEDOT-
CREKA and PEDOT-CR(NMe)EKA films were performed using fibrin and bovine 
serum albumin (BSA, Fraction V). BSA, which is a globular plasma protein, was used 
as a control to study the selectivity of the examined surfaces. The detection of the 
adsorbed proteins was carried out using the Bradford method. Details about the 
experimental protocol are provided in the S.I. 
 
2.4. Cell Capture Assays.  
Substrates were placed into a 24-well plate, and 1 mL of cell MCF-7 (breast cancer 
cell line), PNT2 (normal prostate epithelial cell line) or PC-3 (cancer prostate epithelial 
cell line) suspension (10
5
 cells/mL) was loaded. After incubation for 30 min at 37 ºC, 
5% CO2 with slight agitation (80 rpm), the substrates were washed with PBS, located in 
a new 24-well plate and incubated for 24 hours. The percentage of cells adhered in the 
substrate with respect to the amount deposited into the well was determined using the 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphe- nyltetrazolium] method. Cell capture 
assays were repeated two times with at least 4 replicas, showing similar results in all 
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cases. Details about the protocol followed for observation of the cell morphology by 
SEM are provided in the S.I. 
 
3. Results and Discussion 
3.1.  PEDOT-Peptide Characterization 
The synthetic approach used in this work to prepare PEDOT (control) and PEDOT-
peptide bilayered films is summarized in Figure 1. In order to overcome the fragility of 
PEDOT-peptide films, an internal PEDOT layer was electrodeposited between the steel 
and the biocomposite. The average thickness (L) of the internal PEDOT layer was L= 
15035 nm. Bilayered systems containing an external PEDOT, PEDOT-CREKA or 
PEDOT-CR(NMe)EKA layer deposited onto the internal layer exhibited L values of 
34072, 57357 or 49835 nm, respectively. These L values, which were achieved by 
depositing the external layer immediately after polymerize the internal PEDOT layer, 
are considerably smaller than those reported in for bilayered PEDOT-CREKA (L= 
3.81.3 m).[2] Thus, in the latter case the apparition of multiple, prominent, and well-
localized folds homogeneously distributed was promoted by drying during several hours 
the internal layer before the deposition of the external layer.
[2]
 Accordingly, elimination 
of the drying process induces significant changes not only in L but also on the properties 
(see below) despite the experimental conditions used for the anodic polymerization are 
practically identical.  
Comparison of the root mean square roughness (Rq) determined by AFM for the 
external layer of PEDOT, PEDOT-CREKA or PEDOT-CR(NMe)EKA ( Rq= 749, 
13323 and 16111 nm, respectively) indicates that the peptide affects the surface 
topography (Figure 2). PEDOT’s surface can be described as a very homogeneous 
distribution of small molecular aggregates, which has been associated with the linear 
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growing of polymer chains.
[19]
 Incorporation of CR(NMe)EKA or CREKA into the 
polymeric matrix provokes a drastic change in the topography that exhibits high and 
relatively large compact blocks, explaining the enhancement of Rq. These blocks, which 
result from the aggregation of small clusters over the polymer surface, are essentially 
induced by the role of the peptide as doping agent. Thus, peptide molecules 
(individually or forming clusters) embedded into the PEDOT matrix alter the growing 
of polymer chains, which should perpendicular to the electrode surface. As PEDOT 
chains tend to grow forming clusters,
[20]
 the tilting induced by the peptide facilitates the 
aggregation of neighboring clusters. These phenomena are more pronounced for 
PEDOT-CR(NMe)EKA than for PEDOT-CREKA. 
PEDOT and PEDOT-peptide composites were characterized by XPS. The atomic 
percent composition (C 1s, N 1s, O 1s and S 2p) of the three systems are compared in 
Table 1. As it can be seen, nitrogen was detected in the composition of the three 
systems. According to the experimental conditions used in this work, the penetration of 
X-ray radiation is expected to be of 10 nm. Although the thickness of the bilayered 
films prepared in this work ranged from 300 to 600 nm, examination by SEM 
revealed some uncoated regions of the steel substrate. Accordingly, the presence of N 1s 
in PEDOT films has been attributed to the metallic substrate.
[21]
 It is worth noting that 
the N 1s content increases from 0.47% in PEDOT to 1.20% and 0.92% in PEDOT-
CREKA and PEDOT-CR(NMe)EKA, respectively, reflecting the successful 
incorporation of the peptides.  
Assuming that the nitrogen coming from the steel substrate is approximately the 
same for the three systems, the number of polymer repeat units per peptide molecule in 
PEDOT-CREKA and PEDOT-CR(NMe)EKA can be roughly estimated using the 
S/(Np–Ns) ratio (Table 1), where S is the total percent composition of sulfur atoms and 
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(Np–Ns) refers to the difference between the total percent composition of nitrogen at 
PEDOT-peptide and PEDOT. According to this approximation, the content of peptide in 
PEDOT-CREKA and PEDOT-CR(NMe)EKA is relatively high with one peptide 
molecule every 10 and 15 polymer repeat units, respectively. The smaller content of 
immobilized peptide molecules in PEDOT-CR(NMe)EKA is due to the increment of the 
molecular volume provoked by the N-methylation of the Glu residue, which enhanced 
peptide–polymer steric interactions during the polymerization process.  
Figure 3 displays the high-resolution XPS spectra in the N 1s region, which is crucial 
to prove the immobilization of the peptide into the ECP matrix, for PEDOT, PEDOT-
CREKA and PEDOT-CR(NMe)EKA. The peak centered around 402 eV, which was 
detected in all examined samples including PEDOT ones, is consequence of impurities 
of the AISI 316 steel (see above).
[21]
 However, the intense peak found at 400.2 eV for 
both PEDOT-CREKA and PEDOT-CR(NMe)EKA corresponds to the peptides. Thus, 
this peak is typically explained as a combination of the guanidinium (400.1 eV) and the 
backbone amide (400.5 eV) signals.
[22]
 Bhattacharyya and Gleason attributed the 
presence of N 1s characteristic peaks at 399.7 eV (–NH) and 400.4 eV (N–C=O) to 
bovine serum albumin attached to the surface of a copolymer of thiophene-3-acetic acid 
and EDOT.
[23] 
 Similarly, the XPS N–H signal of Boc-Val-Gly-Gly-Val-Gly-OEt and 
poly(Val-Gly-Gly-Val-Gly) were identified at 400.0 and 400.2 eV, respectively.
[24]
 
Electrochemical properties of PEDOT improve upon the incorporation of the peptide, 
independently of the chemical modification at the Glu residue. Figure 4a shows that the 
electroactivity of both PEDOT-peptide systems is around 15% higher than that of 
PEDOT. These results are consistent with the role of CREKA and CR(NMe)EKA 
molecules as dopant ions, participating in oxidation and reduction processes. This 
achievement, which is in marked contrast previous results,
[2]
 is due to the elimination of 
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the drying step before the deposition of the external layer.  The presence of the peptide 
also enhances the electrochemical stability of PEDOT, as is reflected by the control 
voltammograms recorded after five consecutive oxidation-reduction cycles in PBS 
(Figure 4b). After such amount of cycles, the electroactivity of PEDOT is lower than 
that of PEDOT-CREKA and PEDOT-CR(NMe)EKA by 20% and 30%, respectively. 
Analysis of the LEA (Equation 1) shows a reduction of 15% and 25% for PEDOT-
peptide and PEDOT, respectively, after 5 redox cycles (Figure 4c).  
The reduction of the electroactivity with the number of redox cycles is related with 
the structural degradation of the polymeric matrix that becomes less porous (i.e. more 
compact), making difficult the escape and entrance of dopant ions during the oxidation 
and reduction processes, respectively. In the case of PEDOT-CREKA and PEDOT-
CR(NMe)EKA, the peptides impart protection to the matrix preventing its structural 
degradation. Although determination of such protection mechanism is not an easy task, 
our hypothesis is based on a steric protection due to the formation of nanometric and 
insoluble peptide aggregates inside the polymeric matrix. These could act as structural 
support avoiding the collapse of the polymeric matrix and maintaining the porosity.  
 
3.2. Influence of the Peptide in Fibrinogen Polymerization 
In order to mimic the extracellular conditions where CR(NMe)EKA is able to 
selectively bind into tumor regions, the affinity of the this peptide towards fibrin has 
been compared with that CREKA. The formation of fibrin networks is the central event 
in vertebrates blood coagulation
[25,26]
 and is involved in several pathologies like 
thrombosis and cancer metastasis.
[26,27] 
From a physiological point of view, it represents 
the end of the
 
coagulation cascade when THR activates the inactive
 
precursor Fg.
[26,28]
 
Cleavage and removal of fibrinopeptides from Fg by THR promote the interaction 
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between neighboring fibrin molecules that self-associate to form elongated fibers and 
fiber networks.
[12,29] 
The effect of the peptides on fibrin THR-catalyzed polymerization was assessed at 
37 ºC by DLS. Figure 5 represents the temporal evolution of the effective diameter 
(Deff) of Fg particles using conditions optimized to examine the early steps in fibrin 
polymerization
[30]
 (i.e. 0.4 mg/mL Fg aqueous solution containing 5 mM CaCl2 and 76 
mM NaCl). In absence of THR, Deff stabilizes at 32 nm (Figure 5a) indicating 
significant restrictions in association process (i.e. hydrodynamic radius of Fg is 13 
nm
[31]
). Instead, Deff grows rapidly and progressively over time upon the incorporation 
of THR (Figure 5a). The value of Deff reaches a plateau after 55 min at approximately 
2.5 m, which corresponds to the THR-induced fibrin polymerization.[12]  
The influence of CREKA and CR(NMe)KA in fibrin polymerization was studied by 
adding each peptide to Fg aqueous solutions with and without THR (Figure 5b and 5c). 
In absence of enzyme, the increase of Deff reflects that the two peptides promote the 
aggregation of Fg, even though quantitative differences in the aggregation mechanism 
are revealed. CREKA induces a sustained linear increase of Deff, which grows from 45 
nm (t= 1 min) to 191 nm (t= 60 min). In contrast, CR(NMe)EKA provokes a very fast 
aggregation process at the initial stage (Deff 380 nm at t= 1 min), the growing of the 
microparticles remaining practically stopped after this event (Deff 347 nm at t= 60 
min). Interestingly, incorporation of the peptides to the Fg solution in presence of THR 
results in very fast aggregation process. Thus, the Deff value of the particles formed at t= 
1 min is 271 and 574 nm for CREKA and CR(NMe)EKA, respectively. After this 
initial stage, the size of particles progressively increased, even though the peptide 
largely influenced the growth rate. In the case of CREKA the growth rate of the 
particles (6.90.3 nm/min from Figure 5b) decreased considerably with respect to the 
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same solution without peptide (50.51.8 nm/min from Figure 5a). After a liner growth 
regime, Deff stabilized around 712 nm, which represents a reduction of around 72 % 
with respect to the value obtained for the same solution but without CREKA. After a 
very fast formation stage, the growth rate of the particles formed in presence of 
CR(NMe)EKA progressively increases (14.10.3 nm/min from Figure 5c), stabilizing at 
Deff 1343 nm after 55 min. Accordingly, both peptides disturb the THR-induced fibrin 
polymerization, even though such effect is significantly more pronounced for CREKA.  
In an early work, Carr et al.
[32]
 proved that positively charged poly(-amino acid)s 
enhance lateral association of fibrin protofibrils during fiber bundling. This 
phenomenon was attributed to the charge and isoelectric point of such polypeptides. 
High pKa values facilitated strong interaction between the protofibrils and the poly(-
amino acid), independently of the molecular weight, promoting fibrin polymerization, 
as was evidenced by the increase of fibrin fibers diameter.
[32]
 In contrast, no effect was 
observed for negatively charged poly(-amino acid)s. Both CREKA and CR(NMe)EKA 
have an isoelectric point of 8.55 and, therefore, they are positively charged at working 
pH (7.4). Accordingly, such peptides could promote the lateral assembly of fibrin 
protofibrils, reducing the elongation capability of fibers, as suggested in Figure 5.  
 
3.3. Adsorption of Fibrin onto PEDOT-Peptide Films 
The selective adsorption of fibrin by PEDOT-peptide biocomposites has been 
examined by comparing with the adsorption of BSA, which is a globular plasma 
protein. Results indicate that the affinity of PEDOT-CREKA and PEDOT-
CR(NMe)EKA toward fibrin fibers was ~2.5 and ~6 times higher than that of PEDOT 
(Figure S1), respectively. Thus, 6%, 14% and 37% of the fibrin from the initial 
solution was adsorbed onto PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA, 
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respectively. In contrast, the adsorbed BSA was very scarce (i.e. 8% for PEDOT-
CR(NMe)EKA and lower than 2% for PEDOT and PEDOT-CREKA). The selectivity 
of PEDOT-CR(NMe)EKA towards fibrin suggests that the distribution of the charged 
groups in this biocomposite is appropriated for the adsorption of fibrin despite the loss 
of its fibrous structure (see below). However, such distribution is much less suitable for 
the adsorption of globular proteins, like BSA, in which polar groups are expected to be 
randomly distributed.  
The morphology of fibrin adsorbed onto PEDOT-peptide films was studied by SEM 
(Figure 6). For this purpose, the THR-catalyzed polymerization of Fg was stopped after 
60 min by the addition of formaldehyde
[30]
 (2.5%) and, subsequently, dehydrated using 
30%, 40%, 70%, 90% and 100% ethanol solutions. Amazingly, the formaldehyde-fixed 
fibrin onto PEDOT-peptide surfaces does not exhibit the expected mesh of fibers (see 
below)
[32,33]
 but forms agglomerates of micrometric dimensions with very varied 
morphologies. Thus, agglomerates of fibrin adsorbed onto PEDOT-CREKA (Figure 6a) 
were relatively small (1-4 m) and displayed different round-like morphologies, 
including the spherical one. In contrast, fibrin adsorbed onto PEDOT-CR(NMe)EKA 
presents a larger variety of morphologies, including fiber-like, round-like and 
completely irregular ones (Figure 6b). As the elongated fiber-like morphologies were 
relatively infrequent and isolated rather than immersed into a mesh, they have been 
related with structures formed without the participation of the peptide. Furthermore, 
fibrin aggregates adsorbed onto PEDOT-CR(NMe)EKA are typically bigger than those 
deposited onto PEDOT-CREKA. Overall, results suggest that the round-like and 
irregular morphologies of fibrin adsorbed onto PEDOT-peptide are controlled by the 
fast aggregation processes occurring at early stages of the polymerization process, 
which is consistent with the DLS observations (Figure 5). The area and aspect ratio 
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(AR), which is defined by the ratio between length and diameter, of the morphologies 
observed for the 60 min formaldehyde-fixed products, were determined with the ImageJ 
software using SEM micrographs. Results indicate that the distribution of both areas 
and AR (Figure S2) are influenced by the peptide. Thus, 6% of structures formed onto 
PEDOT-CR(NMe)KA shows an area higher than 10 m2, such amount being 
imperceptible for PEDOT-CREKA. Moreover, 8.8% and 20.3% of the structures 
formed onto PEDOT-CREKA and PEDOT-CR(NMe)KA, respectively, exhibit an AR > 
2.0, reflecting the sporadic formation of isolated fibril-like structures in the latter 
(Figure 6b). 
In order to further confirm the presence of fibrin onto PEDOT-peptide surfaces, the 
two biocomposites together with steel and PEDOT were stained with eosin. Figure 7 
compares optical microscopy images of red colored fibrin polymerized with THR 
during 60 min. Although fibrin is apparently able to bind all tested surfaces, differences 
in the amount of adsorbed proteins indicate a certain degree of selectivity. Thus, a 
typical intertwined mesh of long fibers oriented in multiple directions is observed when 
fibrin is deposited onto bare steel (Figure 7a). PEDOT affects drastically the fibrin 
morphology, inducing the formation of small and rounded-like agglomerates after 60 
min (Figure 7b). The abundance of these aggregates is very scarce in comparison to 
those adsorbed onto steel, which is fully consistent with Bradford protein assays (Figure 
S1). Thus, the adsorption and morphology of fibrin is largely influenced by the 
roughness and/or chemical nature of the substrate. Dolatshahi-Pirouz et al.
[33]
 showed 
that fibrin polymerization and, therefore, fibrillation are slower on flat than on rough 
surfaces. Nevertheless, steel (Rq= 52 nm) is flatter than bilayered PEDOT films (Rq= 
749 nm), evidencing that the chemical nature of the surface is also regulating fibrin 
polymerization and morphology. The chemical nature influence is apparently reflected 
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by the surface hydrophilicity, which is considerably higher for PEDOT and PEDOT-
peptide than for steel (Table 2).  
The hydrophilicity of PEDOT-peptide is similar to that of PEDOT (Table 2), even 
though the roughness is higher for the formers (Rq= 13323 and 16111 nm for 
PEDOT-CREKA and PEDOT-CR(NMe)EKA, respectively) than for the latter (Rq= 
749 nm). Microscopy images displayed in Figure 7b-7d indicate that the fibrin 
polymerization rate onto PEDOT-containing surfaces increases with the roughness, 
which is in agreement with the findings of Dolatshahi-Pirouz et al.
[33]
 Thus, the amount 
of adsorbed fibril increases as follows: PEDOT < PEDOT-CREKA < PEDOT-
CR(NMe)EKA.  
Comparison between the CAs for the different surfaces without and with adsorbed 
fibrin reveals differences in the wettability (Table 2), especially for PEDOT and 
PEDOT-peptide systems. Thus, the highly hydrophilic character of such CP and its two 
biocomposites (CA < 20º) transforms into hydrophobic (CA > 90º) upon the adsorption 
of fibrin particles. This effect is much less pronounced for steel. The transformation of 
Fg into fibrin was reported to be accompanied by a change in the wettability from very 
hydrophilic (Fg) to moderately but definitely hydrophobic (fibrin).
[34]
  
 
3.4. Influence of Fibrin in PEDOT-Peptide Electrochemical and Electrical 
Properties 
Control voltammograms of PEDOT and PEDOT-peptide films coated with fibrin are 
displayed in Figure S3. Comparison with those reported in Figure 4a indicates that the 
adsorbed protein affects negatively the electrochemical response of both the ECP and 
the biocomposites. More specifically, the adsorption of fibrin reduces the electroactivity 
of PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA by 35%, 50% and 51%, 
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respectively. The adsorbed protein also affects negatively to the electrochemical 
stability of the two biocomposites. Thus, after only 5 consecutive redox cycles, the LEA 
is 18%, 22% and 25% for PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA, 
respectively. Accordingly, the behavior of the biocomposites relative to the ECP is in 
terms of electrostability the opposite that the one displayed in absence of fibrin (Figure 
4b). These results should be attributed to the combination of two related effects: (i) the 
amount of protein at the surface of the biocomposites is considerably higher than at the 
surface of PEDOT; and (ii) protein aggregates are more compact than polymeric and 
biocomposite matrices. Accordingly, the exchange of ions between the matrix and the 
PBS electrolytic medium during redox processes is more difficult at regions covered by 
the protein, which are more abundant at the biocomposites than at PEDOT.  
A similar behaviour was observed by EIS analyses. The electrode impedance is 
related to the interfacial surface area between the electrode and electrolyte. The bare 
metal only exhibits a low double layer capacitance (CPEdl) and a high polarization 
resistance coming from the interaction between the ions of the electrolytic medium 
(PBS) and the heterogeneous steel surface (Rp) (Figure 8a). On the other hand, the 
impedance of the electrodes covered with a semiconducting material is more complex 
and other time constants can appear due to several interfaces. More specifically, the 
impedance of PEDOT-coated electrodes decreases three orders of magnitude with 
respect to the bare metal across frequencies between 0.01–10 Hz, which correspond to 
the zone of the coating resistance. This must be attributed, at least partially, to an 
increase in the effective surface area, which is provided by the porous PEDOT 
electrode. The coating resistance (Rc), which is identified from the first diameter of the 
semicircle in the Nyquist plots (Figure S4), describes the resistance for transferring the 
electrons from the PBS ions to the conducting polymer film.  
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The diffusion of ions across the films is enhanced upon the incorporation of peptide 
to PEDOT, leading to lower Rc values (Table 3). The Rc of fibrin-coated PEDOT-
peptide films is higher than that of biocomposites without fibrin (Table 3) since the 
protein aggregates block the pores (i.e. barrier effect). This behaviour is more 
pronounced for PEDOT-CR(NMe)KA, supporting that fibrin interacts more favourably 
with CR(NMe)KA than with CREKA. Furthermore, another constant phase element 
(CPEdif , with n= 0.90) is required to model the response of PEDOT-CR(NMe)KA with 
fibrin (Figure 8b). This is probably due to favourable fibrin···peptide interactions, 
which cause a slow diffusion of ions at very low frequency range. The best-fit values for 
the adjusted resistances and capacitances are listed in Table 3.  
 
3.5. Cell Capture Selectivity: Tumor versus Normal Cells  
PEDOT and PEDOT-peptide samples have been used to investigate the effect of 
fibrin adsorption on cell capturing with MCF-7 cells (breast cancer cell line). Results, 
which are displayed in Figure 9a, clearly indicate that MCF-7 cells are captured more 
efficiently by the biocomposites than by PEDOT. Moreover, the highest cell viability 
was obtained for PEDOT-CR(NMe)EKA coated with fibrin evidencing that such ECP-
peptide-protein biocomposite is a very promising material for biomedical applications. 
Representative SEM micrographs of cells adhered to PEDOT-CR(NMe)EKA without 
and with fibrin are displayed in Figures 9b and 9c, respectively.  
On the other hand, the ability of PEDOT-peptide biocomposites to differentiate 
between tumor and normal cells was examined by conducting cell attachment assays 
using normal (PNT2) and metastatic (PC-3) prostate epithelial cell lines. Results 
displayed in Figure 9d indicate that the amount of normal and tumor attached cells is 
practically the same for the two uncoated biocomposites, no clear preference being 
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exhibited. Moreover, the influence of the peptide is practically negligible since the cell 
attachment was practically the same for PEDOT and PEDOT-peptide films. However, 
assays considering biocomposite films coated with fibrin reveal not only an 
enhancement of cell attachment but also of cell identification (Figure 9d), i.e. normal 
cells vs tumor cells. Thus, both PEDOT-CREKA and PEDOT-CR(NMe)EKA films 
with adsorbed fibrin promoted the adhesion of tumor cells with respect to normal cells 
by around 12%. Moreover, the capture of PNT2 cells is slightly less efficient for 
biocomposites with adsorbed fibrin than without such protein. Overall results suggest 
that cell capture selectivity depends on a balance between different factors, which 
include surface roughness and morphology in addition to chemical structure.  
SEM micrographs of PC3 cells adhered onto fibrin-coated PEDOT-CR(NMe)EKA 
and non-coated PEDOT films are displayed in Figures 9e and 9f, respectively. The 
former ECP-peptide-protein composite promotes cell attachment, as is clearly reflected 
by both the formation of multiple inter-cell connections and a very homogeneous 
spreading of the adhered cells. These features are less evident in Figure 9f, which 
exhibits not only a lower number of cells but also much less connections among them. 
 
4. Conclusions 
PEDOT-peptide biocomposites have been prepared by chronoamperometry in basic 
aqueous solution. The electrochemical and electrical response of the resulting 
biocomposites is significantly better than that of the ECP in terms of electroactivity, 
electrostability and electrical conductivity. Such improvement suggests that peptide 
molecules play simultaneously two roles acting, on one side, as dopant agents that 
participate actively in oxidation and reduction processes and, on the other side, as 
structural supports that preclude the degradation of the ECP during redox processes. 
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The replacement of Glu by NMe-Glu in the peptide alters the surface topology of the 
biocomposite, entrapped CR(NMe)EKA forming bigger aggregates than CREKA. 
Both CREKA and CR(NMe)EKA affect the fibrin THR-catalyzed polymerization 
inducing a very fast aggregation process. However, in absence of catalytic enzyme such 
fast aggregation phenomenon is only promoted by CR(NMe)KA, whereas CREKA 
induces a stepwise linear grow of fibrin particles. This behavior is fully consistent with 
the ability of the different materials to adsorb fibrin at the surface, which grows in the 
following way: PEDOT < PEDOT-CREKA < PEDOT-CR(NMe)EKA. The two 
PEDOT-peptide biocomposites, which adsorb selectively fibrin, transform the shape of 
the adsorbed protein from the typical mesh of fibers to agglomerates with different 
round-like morphologies. This remarkable change has been attributed to the fact that the 
morphology of fibrin adsorbed onto the biocomposites is kinetically controlled through 
the very rapid aggregation process detected at the early stages of the Fg polymerization.  
Cell adhesion assays have evidenced that PEDOT-peptide-fibrin films promote the 
attachment of metastatic cells with respect to that of normal cells. However, this clearly 
manifested selectivity towards tumor cells is lost in absence of the fibrin coating. The 
overall of the results obtained in this work for PEDOT-CR(NMe)EKA films are 
currently used to develop new biomedical applications based on hollow nano- and 
microspheres of such biocomposite.    
 
Supporting Information 
Supporting Information is available from the Wiley Online Library or from the 
author. 
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Table 1. Atomic percent composition (C 1s, N 1s, O 1s and S 2p) and S 2p / N 1s ratio 
obtained by XPS for PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA. 
 
# C 1s N 1s O 1s S 2p S / N 
PEDOT 68.64 0.47 23.82 7.07 - 
PEDOT-CREKA 68.57 1.20 23.06 7.17 5.97
 
PEDOT-CR(NMe)EKA 69.46 0.92 22.74 6.88 7.48
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Table 2. Contact angle (CA) determined for the surfaces examined in this work before 
and after adsorption of fibrin. 
 
Surface CA 
Steel 68º±5º 
PEDOT < 20º 
PEDOT-CREKA < 20º 
PEDOT-CR(NMe)EKA < 20º 
Steel / fibrin 94º±4º 
PEDOT / fibrin 112º±1º 
PEDOT-CREKA / fibrin 114º±2º 
PEDOT-CR(NMe)EKA / fibrin 107º±4º 
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Table 3. Resistances (R) and constant phase elements (CPE) for each sample analysed with EIS technique and after adjusting the parameters 
using the electrical equivalent circuit (EEC) shown in Figure 8b. 
Sample 
Rs 
a) 
(Ω.cm
2
) 
Rc 
b) 
(Ω.cm
2
) 
CPEc 
c) 
(F cm
−2
 s
n−1
) 
n 
Rp 
d) 
(Ω.cm
2
) 
CPEdl 
e) 
(F cm
−2
 s
n−1
) 
n 
CPEdif 
f) 
(F cm
−2
 s
n−1
) 
n 
Stainless steel (bare) 123 
- 
- - 594k
g)
 3.85×10
-5
 0.85 - - 
PEDOT 162 267 4.03×10
-5
 0.83 - 1.08×10
-3
 0.76 - - 
PEDOT-CREKA 100 188 1.00×10
-4
 0.74 - 1.12×10
-3
 0.93 - - 
PEDOT-CREKA with fibrin 155 209 3.49×10
-5
 0.73 - 1.23×10
-3
 0.91 - - 
PEDOT-CR(NMe)EKA 119 128 2.29×10
-4
 0.54 - 0.82×10
-3
 1.00 - - 
PEDOT-CR(NMe)EKA with fibrin 97 294 6.30×10
-4
 0.63 138
h) 
0.87×10
-3
 1.00 2.25×10
-4
 0.90 
a) 
Rs = solution resistance, 
b) 
Rc = Coating resistance, 
c) 
CPEc = coating capacitance, 
d) 
Rp = polarization resistance,
 e)
 CPEdl = double layer 
capacitance
 f) 
CPEdif = diffusion capacitance,
 g)
 Value of resistance for the stainless steel bare (without conducting polymer) is attributed to the 
polarization resistance (Rp) in the electrode/electrolyte interface at low frequency. 
h)
 This parameter is better related to the Rdif = ion diffusion 
resistance across the film (see the last EEC in Figure 8b). 
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CAPTIONS TO FIGURES 
Figure 1. Scheme displaying the synthetic strategy used to prepare PEDOT (control) 
and PEDOT-peptide bilayered films (a and b, respectively). The strategy involved a 
two-step process: (1) deposition of the internal PEDOT layer onto the AISI steel 
electrode; and (2) deposition of PEDOT (a) or PEDOT-peptide (b) onto the layer 
prepared in (1). It is worth noting that a and b only differ in the absence or presence of 
peptide in the generation medium used for step 2. After this, subsequent surface 
functionalization with fibrin and application as selective bioactive surface are also 
displayed. RE, WE and CE refer to the reference electrode, working electrode and 
counter electrode, respectively. 
Figure 2. Topographic (3D) and heigh (2D) AFM images of (a) PEDOT, (b) 
PEDOT-CREKA and (c) PEDOT-CR(NMe)EKA.  
Figure 3. High-resolution XPS spectra in the N 1s region for (a) PEDOT, (b) 
PEDOT-CREKA and (c) PEDOT-CR(NMe)EKA. Peaks from deconvolution are also 
displayed.  
Figure 4. Initial control voltammogram (a), voltammogram after five consecutive 
oxidation-reduction cycles (b) and variation of the LEA (Eq 1) against the number of 
redox cycles (c) in 0.1 M PBS (pH= 7.4) of PEDOT, PEDOT-CREKA and PEDOT-
CR(NMe)EKA. Initial and final potentials: -0.40 V; reversal potential: 0.80 V. Scan 
rate: 50 mV/s. 
Figure 5. (a) THR-catalyzed polymerization of Fg monitored by DLS. 
Polymerization was initiated by adding THR (0.01 U/mL) to a Fg (0.4 mg/mL) filtered 
aqueous solution (5 mM CaCl2 and 76 mM NaCl). These experimental conditions were 
taken from reference [30]. Polymer formation was measured through the the effective 
diameter (Deff , in nm) as a function of time (in min). CREKA (b) and CR(NMe)EKA 
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(c) were added (0.1 mg/mL) to the same Fg solutions with and without THR to evaluate 
the influence of the peptide in the polymerization process. In all cases data correspond 
to the average of at least three independent experiments. 
Figure 6. Low and high resolution SEM images of fibrin particles adsorbed onto (a) 
PEDOT-CREKA and (b) PEDOT-CR(NMe)EKA. White boxes in (a) and (b) indicate 
the magnified regions. 
Figure 7. Optical images of eosin stained fibrin adsorbed on (a) steel, (b) PEDOT, 
(c) PEDOT-CREKA and (d) PEDOT-CR(NMe)EKA. 
Figure 8. (a) Bode plots for all stainless steel electrodes coated with PEDOT-peptide 
without and with fibrin adsorbed at the surface. (b) Electrical equivalent circuits for bare 
steel, steel coated with PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA without 
and with fibrin adsorbed at the surface (see Table 3).  
Figure 9. (a) Percentage of MCF-7 cells attached to different surfaces: bare steel, 
PEDOT, biocomposites, and biocomposites coated with fibrin. In all cases data 
correspond to the average of five independent assays  the standard deviation. Asterisk 
marks (*) and (***) represent significant difference among the samples at p < 0.05 and 
p < 0.001, respectively. SEM micrographs of MCF-7 cells onto PEDOT-CR(NMe)EKA 
films (b) without and (c) with adsorbed fibrin at the surface. (d) Comparison of the 
percentage of normal (PNT2) and metastatic (PC3) prostate epithelial cells attached to 
different surfaces. The description of both the surfaces and the marks is identical to that 
given for (a). SEM micrographs of PC-3 cells onto (e) PEDOT-CR(NMe)EKA and (f) 
and PEDOT films. Scale bar: 20 m. 
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Figure 9 
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Experimental Methods 
Materials. 3,4-ethylenedioxythiophene (EDOT) monomer and dodecylbenzene 
sulfonate (SDBS) were purchased from Aldrich and used as received without further 
purification. CR(NMe)EKA and CREKA peptides with > 98% of HPLC purity was 
purchased from Biomatik (Toronto, ON). Ultrapure milliQ water was used to prepare all 
the aqueous solutions. Fibrinogen from human plasma (50-70% protein;  80% of 
protein is clottable) was purchased from Sigma (F3879). Cell lines MCF-7 (epithelial 
cells from human breast adenocarcinoma), PNT2 (normal prostate epithelium 
immortalized with SV40), and PC-3 (epithelial cells from human prostate 
adenocarcinoma) were obtained from ECACC (European Collection of Cell Culture, 
UK). Culture media were purchased from BD Gibco (Franklin Lakes, NJ, USA. 
Synthesis. Anodic polymerization and electrochemical assays were performed with 
an Autolab PGSTAT302N equipped with the ECD module (Ecochimie, the 
Netherlands) using a three-electrode compartment cell under nitrogen atmosphere 
(99.995% pure) at room temperature. Steel AISI 316 sheets of 0.5 and 1 cm
2
 in area 
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were used as working and counter electrode, respectively. The reference electrode was 
an Ag׀AgCl electrode containing a KCl saturated aqueous solution.  
PEDOT-CR(NMe)EKA and PEDOT-CREKA films were prepared by 
chronoamperometry using an aqueous medium pH = 10.3 (adjusted with 1 M NaOH) 
and a constant potential of 1.10 V, which has been identified as the optimum potential 
for the polymerization of EDOT in water.
1
 A two-step process was used. First, steel 
electrode was coated with a layer of PEDOT. For this purpose, the anodic compartment 
of the cell was filled with 20 mL of a 20 mM EDOT aqueous solution containing 10 
mM SDBS as supporting electrolyte, while the cathodic compartment was filled 10 mL 
of the same electrolyte solution. The polymerization time used for the electrodeposition 
of this PEDOT coating layer was of = 10 s. After this, a second layer of PEDOT-
CR(NMe)EKA or PEDOT-CREKA was electrodeposited onto the surface of the 
PEDOT coating layer. This was achieved by filling the anodic compartment with a 
generation solution identical to that described above for the internal PEDOT layer but 
containing 1 mg/mL of CR(NMe)EKA or CREKA peptide. The applied potential and 
the polymerization time employed for the preparation of the second layer were 1.10 V 
and = 20 s, respectively. It should be remarked that the biocomposite layer was 
deposited onto the internal PEDOT layer immediately after the generation of the latter. 
This represents an important difference with respect to our previous work,
2
 in which the 
PEDOT-CREKA layer was deposited after dry during several hours the internal PEDOT 
layer. 
PEDOT films used as control were prepared employing the same experimental 
conditions that for PEDOT-CREKA and PEDOT-CR(NMe)EKA biocomposites but 
without the peptide addition in the second layer (i.e. two PEDOT layers prepared using 
polymerization times of 10 s and 20 s).  
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Contact profilometry. Film thickness measurements were carried out using a Dektak 
150 stylus profilometer (Veeco, Plainview, NY). Scratches were intentionally provoked 
on the film surface and the average thickness was determined from, at least, nine 
measurements for each condition. Imaging of the films was conducted using the 
following optimized settings: tip radius= 12.5 µm; stylus force= 3 mg; scan length= 2 
µm; speed= 2 nm/s. 
Atomic Force Microscopy (AFM). AFM was conducted to obtain topographic 
images of the films surface using silicon TAP 150-G probe (Budget Sensors, Bulgaria) 
with a frequency of 150 kHz and a force constant of 5 N/m. Images were obtained with 
a AFM Dimension microscope using a NanoScope IV controller under ambient 
conditions in tapping mode. The row scanning frequency was set between 0.6 and 0.8 
Hz. The Root Mean Square roughness (Rq), which is the average height deviation taken 
from the mean data plane, was determined using the statistical application of the 
NanoScope Analysis software (1.20, Veeco). AFM measurements were performed on 
various parts of the films, which produced reproducible images similar to those 
displayed in this work. The scan window size was 1010 m2. 
X-ray photoelectron spectroscopy (XPS). XPS analyses were performed in a SPECS 
system equipped with a high-intensity twin-anode X-ray source XR50 of Mg/Al (1253 
eV/1487 eV) operating at 150 W, placed perpendicular to the analyzer axis, and using a 
Phoibos 150 MCD-9 XP detector. The X-ray spot size was 650 mm. The pass energy 
was set to 25 and 0.1 eV for the survey and the narrow scans, respectively. Charge 
compensation was achieved with a combination of electron and argon ion flood guns. 
The energy and emission current of the electrons were 4 eV and 0.35 mA, respectively. 
For the argon gun, the energy and the emission current were 0 eV and 0.1 mA, 
respectively. The spectra were recorded with a pass energy of 25 eV in 0.1 eV steps at a 
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pressure below 610-9 mbar. These standard conditions of charge compensation resulted 
in a negative but perfectly uniform static charge. The C 1s peak was used as an internal 
reference with a binding energy of 284.8 eV. High-resolution XPS spectra were 
acquired by Gaussian–Lorentzian curve fitting after S-shape background subtraction. 
The surface composition was determined using the manufacturer's sensitivity factors. 
Cyclic voltammetry (CV). CV studies were run to assess the electrochemical 
behavior of the biocomposites. Hence, the ability to exchange charge reversibly (i.e. 
electroactivity) and the electrochemical stability (i.e. electrostability) were determined 
using a 0.1 M phosphate buffer saline solution (PBS; pH= 7.4 adjusted with NaOH). 
The initial and final potentials were -0.40 V, whereas a reversal potential of 0.80 V was 
considered. The scan rate was 50 mV/s in all cases.  
The electroactivity increases with the similarity between the anodic and cathodic 
areas of the first control voltammogram. The electrochemical stability (i.e. loss of 
electroactivity, LEA), which decreases with the oxidation and reduction areas of 
consecutive control voltammograms, was determined using the following expression: 
 
 100
iQ
Q
LEA

  (1) 
where ΔQ is the difference of voltammetric charge between the first cycle and the last 
cycle and Qi is the voltammetric charge corresponding to the second cycle. In this work 
all values of LEA were referred to five consecutive oxidation-reduction cycles.  
Dynamic light scattering (DLS). Real-time monitoring of fibrin polymerization in 
presence and absence of peptide at 37 ºC was conducted by DLS following the 
increment of the particle effective diameter. All buffers and fibrinogen (Fg) samples 
were filtered (0.22 µm centrifugal filter) prior to use. Final concentrations of Fg and 
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thrombin (THR) were 0.4 mg/mL and 0.01 U/mL, respectively, in aqueous solution 
containing 5 mM CaCl2 and 76 mM NaCl. Data were collected every minute. 
Measurements were performed using a NanoBrook Omni Zeta Potential Analyzer from 
Brookheaven Instruments Corporation. 
Electrochemical impedance spectroscopy (EIS). Impedance spectroscopy was 
performed using a conventional three-electrode cell and AUTOLAB-302N 
potentiostat/galvanostat operating between the frequency range of 100kHz-10 mHz and 
10 mV of amplitude for the sinusoidal voltage. All experiments were performed with 
films electrochemically deposited on stainless steel substrates (AISI 316L with 1cm
2
 of 
area) and immersed in phosphate buffer saline (PBS, pH 7.4), at room temperature. 
Stainless steel electrodes were used as working and counter-electrodes, whereas 
Ag|AgCl saturated (KCl 3M) was employed as reference electrode. After data 
collection, EIS results were then processed and fitted to an electrical equivalent circuit 
(EEC). 
Protein Adsorption. Analyses to examine the adsorption of proteins onto the surface 
of PEDOT, PEDOT-CREKA and PEDOT-CR(NMe)EKA films were performed using 
fibrin and bovine serum albumin (BSA, Fraction V). BSA, which is a globular plasma 
protein, was used as a control to study the selectivity of the examined surfaces. 
PEDOT and PEDOT-peptide films were placed on a 24-well plate heated at 37 ºC. 
Meanwhile, fibrin precursors, Fg (0.4 mg/mL) and THR (0.01 U/mL) were heated to the 
same temperature (solutions previously filtered). Fg and THR solutions were deposited 
onto the film surface using a 1:1 ratio. After 60 min with slight agitation (80 rpm) the 
film was rinsed in 0.1 M PBS to remove residues and non-specifically bound fibrin. The 
same procedure was used to adsorb BSA, the only difference being the protein 
concentration in the solution (0.4 mg/mL).  
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Detection of adsorbed proteins: Bradford method. Adsorbed fibrin and BSA were 
removed from the films surfaces by adding 0.2 mL of 0.1 M PBS with nonyl 
phenoxypolyethoxyethanol (NP-40) surfactant (0.5% v/v) and orbital shaking at 50 rpm 
during 30 min and 37ºC. In order to avoid interferences between the NP40 surfactant 
and the Bradford reagent, the former was eliminated by precipitating the fibrin with 20 
µL of trichloroacetic acid. Then, the precipitate-containing solution was centrifuged for 
15 min at 12000 rpm. The solid (fibrin or BSA) was washed with cold acetone and 
maintained at 4 ºC for 1 hour. After this, the solid was centrifuged again during 15 min 
at 12000 rpm. The protein was dried under vacuum and, finally, dissolved in 0.1 M PBS 
for Bradford assay.  
Standard curves were carried out using protein dilutions, which were prepared using 
buffer solution with concentrations of protein ranging from 0.05 to 1.00 mg/mL. Next, 5 
µL of protein standards and samples were added to a 96-well plate, blank wells were 
filled with 5µL of buffer. After this, Bradford reagent (250 µL) was added and, 
subsequently, mixed on a shaker for 30 s. Samples were incubated at room temperature 
for 15 min. Finally, the absorbance was measured at 595 nm. 
Scanning electron microscopy (SEM). SEM micrographs were obtained using a 
Focussed Ion Beam Zeiss Neon 40 scanning electron microscope operating at 10 kV. 
Samples were mounted on a double-side adhesive carbon disc and sputter-coated with a 
thin layer of carbon to prevent sample charging problems. The projected area and best-
fit ellipse aspect ratio of fibrin structures were calculated using ImageJ software.  
Optical microscopy. To evaluate the THR-catalysed fibrin particles, samples were 
washed three times with milliQ water to avoid unspecific bindings. After this, fibrin 
particles were fixed onto the surface with 300 µL of 2.5% paraformaldehyde in PBS 
during 30 min at 4 ºC. Then, samples were progressively dehydrated using alcohols of 
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30º, 40º, 50º, 70º, 95º, and 100º for 15 min each at 4 ºC. Samples were stained with 
eosin for 30 min. Eosin is a fluorescent acidic compound that binds positively charged 
molecules (i.e. the isoelectric point of Fg is 5.5, increases to 6.3 after clipping of polar 
residues in the clotting response by THR).  Finally, samples were washed three times 
again with milliQ water and left on vacuum overnight. 
Wettability. Contact angle (CA) measurements were conducted using the water drop 
method. 0.5 µL of milliQ water drops were deposited onto the surface of the films and 
recorded after stabilization with the equipment OCA 15EC (DataPhysics Instruments 
GmbH, Filderstadt). The SCA20 software was used to measure the CA, which is shown 
here as the average of at least 10 measures for each condition. 
Cell capture assays. Substrates were placed into a 24-well plate, and 1 mL of cell 
MCF-7 (breast cancer cell line), PNT2 (normal prostate epithelial cell line) or PC-3 
(cancer prostate epithelial cell line) suspension (10
5
 cells/mL) was loaded. After 
incubation for 30 min at 37 ºC, 5% CO2 with slight agitation (80 rpm), the substrates 
were washed with PBS, located in a new 24-well plate and incubated for 24 hours. The 
percentage of cells adhered in the substrate with respect to the amount deposited into the 
well was determined using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphe- 
nyltetrazolium] method. Cell capture assays were repeated two times with at least 4 
replicas, showing similar results in all cases.  
For the observation of the cell morphology in the scanning electronic microscope, all 
samples were previously coated with a carbon layer of 6−10 nm thickness using a 
K950X Turbo Evaporator to prevent sample charging problems. Before the carbon 
coating, samples covered with cells were fixed in a 2.5% formaldehyde PBS solution 
(pH = 7.2) overnight at 4 °C. Then, they were dehydrated by washing in an alcohol 
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battery (30°; 50°; 70°; 90°; 95°; and 100°) at 4 °C for 15 min per wash. Finally, samples 
were air-dried and sputter-coated with carbon. 
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Figure S1. Adsorption of fibrin and BSA onto the surface of PEDOT and PEDOT-
peptide films. Four samples were analysed for each group. Bars represent the mean ± 
standard deviation. 
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Figure S2. Quantitative assessment of the fibrin particles adsorbed onto PEDOT-CREKA and 
PEDOT-CR(NMe)EKA surfaces. Histogram showing the percentage of (a) the area and (b) the 
aspect ratio (AR) of the adsorbed fibrin structures after 60 min of the addition of THR and Fg. 
 
  
(a) (b)
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Figure S3. Control voltammograms in 0.1 M PBS (pH= 7.4) of fibrin-coated PEDOT, 
PEDOT-CREKA and PEDOT-CR(NMe)EKA films. Initial and final potentials: -0.40 
V; reversal potential: 0.80 V. Scan rate: 50 mV/s.  
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Figure S4. Nyquist plots for all stainless steel electrodes coated with (a) PEDOT-
CREKA and (b) PEDOT-CR(NMe)EKA without and with fibrin adsorbed at the 
surface.  
 
 
(a)
(b)
